In Brief: Matritech
This article was originally published in The Gray Sheet
Executive Summary
Matritech: Firm identifies three cervical cancer-specific nuclear matrix proteins (NMPs) for use as cancer markers on an automated cervical cancer screening analyzer under development at Bayer Diagnostics. The discovery "triggers a milestone payment from Bayer" under a product development and marketing option agreement reached in June 1995 ("The Gray Sheet" June 19, 1995, p. 32)...